Inovio Pharmaceuticals
INO
#9813
Rank
โ‚ฌ86.17 M
Marketcap
0,83ย โ‚ฌ
Share price
4.34%
Change (1 day)
-62.34%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2026 (TTM): -1,56ย โ‚ฌ

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -1,64ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -1,62ย โ‚ฌ an increase over its 2024 EPS that were of -3,55ย โ‚ฌ.

EPS history for Inovio Pharmaceuticals from 1999 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,56ย โ‚ฌ-3.84%
2025-1,62ย โ‚ฌ-54.18%
2024-3,55ย โ‚ฌ-35.14%
2023-5,47ย โ‚ฌ-56.62%
2022-12,60ย โ‚ฌ-19.54%
2021-15,66ย โ‚ฌ35.9%
2020-11,52ย โ‚ฌ-11.57%
2019-13,03ย โ‚ฌ15.24%
2018-11,31ย โ‚ฌ-2.78%
2017-11,63ย โ‚ฌ6.93%
2016-10,88ย โ‚ฌ134.88%
2015-4,63ย โ‚ฌ-29.51%
2014-6,57ย โ‚ฌ-57.34%
2013-15,40ย โ‚ฌ146.55%
2012-6,25ย โ‚ฌ20.83%
2011-5,17ย โ‚ฌ-29.41%
2010-7,32ย โ‚ฌ-48.48%
2009-14,22ย โ‚ฌ10%
2008-12,92ย โ‚ฌ11.11%
2007-11,63ย โ‚ฌ-41.3%
2006-19,82ย โ‚ฌ-66.91%
2005-59,88ย โ‚ฌ110.61%
2004-28,43ย โ‚ฌ-61.63%
2003-74,10ย โ‚ฌ186.67%
2002-25,85ย โ‚ฌ
2001N/A-100%
2000-20,68ย โ‚ฌ-61.27%
1999-53,39ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
7,84ย โ‚ฌ-577.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
5,98ย โ‚ฌ-463.93%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,68ย โ‚ฌ-141.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-2,33ย โ‚ฌ 42.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
1,14ย โ‚ฌ-169.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,87ย โ‚ฌ-274.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
-2,99ย โ‚ฌ 81.97%๐Ÿ‡บ๐Ÿ‡ธ USA